Association of APOA5 rs3135506 and CETP rs708272 Polymorphisms with Metabolic Syndrome in a Moroccan Population

Background: Metabolic syndrome (MetS) is a multifactorial condition and a major public health concern due to its strong association with cardiovascular disease and type 2 diabetes. Genetic factors contribute to its development. This study aims to evaluate the association between polymorphisms in genes APOA5 and CETP and susceptibility to MetS and its components in a Moroccan population. Methods: A case–control study was conducted, including 136 MetS patients and 138 controls recruited from the Doukkala region (Morocco). The APOA5 rs3135506 (C>G) and CETP rs708272 (G>A) polymorphisms were genotyped using PCR-RFLP. Results: The APOA5 rs3135506 polymorphism was significantly associated with increased MetS risk. The CG and GG genotypes conferred 2.39-fold (OR = 2.39; p = 0.0008) and 7.17-fold (OR = 7.17; p = 0.0007) higher risks, respectively, with significant associations also observed under dominant (OR = 2.76; p < 0.0001), recessive (OR = 4.79; p = 0.006), and allelic (OR = 2.36; p < 0.0001) models. The GG genotype was also associated with general and abdominal obesity, hypertension, and hyperglycemia, whereas the CG genotype was associated with dyslipidemia. For CETP rs708272, the AA genotype was associated with increased MetS risk (OR = 3.31; p = 0.0078), with significant associations under dominant (OR = 1.81; p = 0.0160), recessive (OR = 2.80; p = 0.0185), and allelic (OR = 1.81; p = 0.0023) models. However, these associations were no longer significant after adjustment for age and sex. Combined genotype analysis revealed increased MetS risk for the CG–GG, CG–GA, and GG–AA combinations (OR = 4.64, 2.98, and 7.35, respectively). Conclusion: The APOA5 rs3135506 and CETP rs708272 polymorphisms may contribute to MetS susceptibility in the Moroccan population, with certain combined genotypes associated with increased risk. These findings support their potential as genetic biomarkers for early risk assessment but require confirmation in larger studies.

Authors

Institutions

Publication Details

Journal
Genetic Testing and Molecular Biomarkers
Published
2026-10-30
DOI
https://doi.org/10.1177/19450265261503240
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of APOA5 rs3135506 and CETP rs708272 Polymorphisms with Metabolic Syndrome in a Moroccan Population

Oumaima El Alaoui El Abdallaoui, Aïcha Motrane, Fatima-Ezzahra Anaibar, Hamid Farhane et al.
Genetic Testing and Molecular Biomarkers
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Association of APOA5 rs3135506 and CETP rs708272 Polymorphisms with Metabolic Syndrome in a Moroccan Population

Oumaima El Alaoui El Abdallaoui, Aïcha Motrane, Fatima-Ezzahra Anaibar, Hamid Farhane, Nourdin Harich, Said Nassor Abeid, Majida Motrane, Abderraouf Hilali, Soufiane Karchali
article en

Abstract

Background: Metabolic syndrome (MetS) is a multifactorial condition and a major public health concern due to its strong association with cardiovascular disease and type 2 diabetes. Genetic factors contribute to its development. This study aims to evaluate the association between polymorphisms in genes APOA5 and CETP and susceptibility to MetS and its components in a Moroccan population. Methods: A case–control study was conducted, including 136 MetS patients and 138 controls recruited from the Doukkala region (Morocco). The APOA5 rs3135506 (C>G) and CETP rs708272 (G>A) polymorphisms were genotyped using PCR-RFLP. Results: The APOA5 rs3135506 polymorphism was significantly associated with increased MetS risk. The CG and GG genotypes conferred 2.39-fold (OR = 2.39; p = 0.0008) and 7.17-fold (OR = 7.17; p = 0.0007) higher risks, respectively, with significant associations also observed under dominant (OR = 2.76; p < 0.0001), recessive (OR = 4.79; p = 0.006), and allelic (OR = 2.36; p < 0.0001) models. The GG genotype was also associated with general and abdominal obesity, hypertension, and hyperglycemia, whereas the CG genotype was associated with dyslipidemia. For CETP rs708272, the AA genotype was associated with increased MetS risk (OR = 3.31; p = 0.0078), with significant associations under dominant (OR = 1.81; p = 0.0160), recessive (OR = 2.80; p = 0.0185), and allelic (OR = 1.81; p = 0.0023) models. However, these associations were no longer significant after adjustment for age and sex. Combined genotype analysis revealed increased MetS risk for the CG–GG, CG–GA, and GG–AA combinations (OR = 4.64, 2.98, and 7.35, respectively). Conclusion: The APOA5 rs3135506 and CETP rs708272 polymorphisms may contribute to MetS susceptibility in the Moroccan population, with certain combined genotypes associated with increased risk. These findings support their potential as genetic biomarkers for early risk assessment but require confirmation in larger studies.

Genetic Testing and Molecular Biomarkers
Chouaib Doukkali University (MA), Université Hassan 1er (MA), Institut National des Sciences de l'Archéologie et du Patrimoine (MA)
Good health and well-being
Openalex Percentile: Top 11%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon